Alimera sciences names elliot maltz as chief financial officer and reports inducement grant under nasdaq listing rule 5635(c)(4)

Atlanta, jan. 02, 2024 (globe newswire) -- alimera sciences, inc. (nasdaq: alim) (“alimera” or the “company”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners concerned with retinal health, and maintaining better vision longer, today announced that elliot maltz, c.p.a., has been named chief financial officer effective immediately.
ALIM Ratings Summary
ALIM Quant Ranking